Passion IT Framework
Amgen to acquire clinical stage biotechnology firm Teneobio
- ByPassionIT News --
- 2021-07-29
Biotechnology company Amgen has agreed to acquire Teneobio, a privately held clinical stage biotechnology firm, in a deal valued at about $900m.
Read More at:
https://www.pharmaceutical-business-review.com/news/amgen-acquire-biotechnology-firm-teneobio/
Related News
Comment